Apiam Animal Health Ltd (ASX:AHX) speaks with ABN Newswire on the recently released financial results, as well as the company's expansion into regional areas with around 20 acquisitions over the last two years.

Apiam Animal Health Limited (ASX:AHX) today released its full year financial results for the year ended 30 June 2023 (FY23)

Apiam Animal Health Limited (ASX:AHX) will release its financial results for the twelve months ended 30 June 2023 on Monday 28 August 2023.

Apiam Animal Health Limited (ASX:AHX) today announced a market update ahead of the release of its financial results for the year ended 30 June 2023 (FY23).

Apiam Animal Health Limited (ASX:AHX) Managing Director Dr. Chris Richards outlines the Apiam brand and growing business, with veterinary practices joining the Apiam brand.

Apiam Animal Health Limited (ASX:AHX) is pleased to release its full year results for the 6-months to 31 December 2022 (H1 FY23).

Apiam Animal Health Limited (ASX:AHX) will release its financial results for the six months ended 31 December 2022 on Friday 24 February 2023.

Apiam Animal Health Ltd (ASX:AHX) MD Dr. Chris Richards speaks with ABN Newswire on the recent acquisitions the company has made in the mixed animal veterinary industry.

Apiam Animal Health Limited (ASX:AHX) is pleased to announce the acquisition of two mixed animal veterinary businesses in strategic NSW regions (the Acquisitions), for total consideration of $11.2 million.

American Medical Association approves CPT PLA code for PromarkerD predictive test for diabetic kidney disease